Nakada I, Tasaki T, Ubukata H, Goto Y, Watanabe Y, Sato S, Tabuchi T, Tsuchiya A, Soma T
Department of Surgery, Tokyo Medical College Kasumigaura Hospital, Ibaraki, Japan.
Dis Colon Rectum. 1998 Jul;41(7):896-900. doi: 10.1007/BF02235375.
The aim of this study was to evaluate the role of histopathology of biopsy specimens in predicting depth of infiltration in early colorectal carcinomas before treatment.
Early colorectal carcinomas that had been resected surgically or endoscopically between 1984 and 1995 were analyzed. Histopathologic findings, including differentiation of adenocarcinoma and a desmoplastic response were investigated.
One hundred nine early colorectal carcinomas consisted of 73 lesions of carcinoma in situ, 13 submucosal carcinomas with minimum invasion, 8 lesions with moderate invasion, and 15 lesions with deep invasion. Of 73 carcinoma in situ lesions, 72 (approximately 99 percent) showed well-differentiated adenocarcinomas and no desmoplastic response. Twelve (92 percent) of 13 submucosal carcinomas with minimum invasion also revealed well-differentiated adenocarcinoma without a desmoplastic response. Sixty-three percent (5/8) of lesions with moderate invasion revealed well-differentiated adenocarcinoma. None of the lesions had a desmoplastic response. Among lesions with deep invasion, 73 percent (11/15) demonstrated moderately differentiated adenocarcinoma, and 11 lesions had a prominent desmoplastic response (73 percent; P < 0.01).
These results suggest that if histopathologic findings of biopsy specimens taken from them before treatment demonstrated adenocarcinoma associated with a desmoplastic response, the lesions had at least deep invasion carcinomas. These lesions should be resected surgically. Submucosal carcinomas with minimum invasion, which have no desmoplastic response, could be treated endoscopically.
本研究旨在评估活检标本的组织病理学在预测早期结直肠癌治疗前浸润深度中的作用。
分析1984年至1995年间经手术或内镜切除的早期结直肠癌。研究组织病理学结果,包括腺癌分化程度及促纤维增生反应。
109例早期结直肠癌包括73例原位癌、13例最小浸润性黏膜下癌、8例中度浸润性病变和15例深度浸润性病变。73例原位癌病变中,72例(约99%)显示高分化腺癌且无促纤维增生反应。13例最小浸润性黏膜下癌中有12例(92%)也显示高分化腺癌且无促纤维增生反应。8例中度浸润性病变中有63%(5/8)显示高分化腺癌。所有病变均无促纤维增生反应。在深度浸润性病变中,73%(11/15)表现为中分化腺癌,11例有显著促纤维增生反应(73%;P<0.01)。
这些结果表明,如果治疗前取自这些病变的活检标本的组织病理学结果显示腺癌伴有促纤维增生反应,则这些病变至少为深度浸润癌。这些病变应行手术切除。无促纤维增生反应的最小浸润性黏膜下癌可通过内镜治疗。